Skip to Main Content
Center for Cancer ResearchCCR Home | About CCR | CCR Intranet

Headline Title

Neurobehavioral Program

Recent Publications

Pediatric psychologist use of adherence assessments and interventions.
J Pediatr Psychol. 2013 Jul;38(6):595-604. doi: 10.1093/jpepsy/jst025. Epub 2013 May 8

Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromas.
Kim A, Dombi E, Tepas K, Fox E, Martin S, Wolters P, Balis FM, Jayaprakash N, Turkbey B, Muradyan N, Choyke PL, Reddy A, Korf B, Widemann BC.Pediatr Blood Cancer. 2013 Mar;60(3):396-401. doi: 10.1002/pbc.24281. Epub 2012 Sep 7.PMID: 22961690 [PubMed - indexed for MEDLINE]

Diagnosis disclosure, medication hiding, and medical functioning among perinatally infected, HIV-positive children and adolescents.
Calabrese SK, Martin S, Wolters PL, Toledo-Tamula MA, Brennan TL, Wood LV. AIDS Care. 2012;24(9):1092-6. doi: 10.1080/09540121.2012.699670.PMID: 22799616 [PubMed - indexed for MEDLINE]

Social-emotional functioning of children and adolescents with neurofibromatosis type 1 and plexiform neurofibromas: relationships with cognitive, disease, and environmental variables.
Martin S, Wolters P, Baldwin A, Gillespie A, Dombi E, Walker K, Widemann B.J Pediatr Psychol. 2012 Aug;37(7):713-24. doi: 10.1093/jpepsy/jsr124. Epub 2012 Feb 21.PMID: 2235380

A phase 2 study of pegylated interferon ?-2b (PEG-Intron(®)) in children with diffuse intrinsic pontine glioma.
Warren K, Bent R, Wolters PL, Prager A, Hanson R, Packer R, Shih J, Camphausen K.Cancer. 2012 Jul 15;118(14):3607-13. doi: 10.1002/cncr.26659. Epub 2011 Nov 15.PMID: 22086404

Family functioning and coping styles in families of children with cancer and HIV disease.
Martin S, Calabrese SK, Wolters PL, Walker KA, Warren K, Hazra R.Clin Pediatr (Phila). 2012 Jan;51(1):58-64. doi: 10.1177/0009922811417300. Epub 2011 Aug 25.PMID: 21868594

Experiences of families with a child, adolescent, or young adult with neurofibromatosis type 1 and plexiform neurofibroma evaluated for clinical trials participation at the National Cancer Institute.
Martin S, Gillespie A, Wolters PL, Widemann BC.
Contemp Clin Trials. 2010 Oct 14. [Epub ahead of print]

A comparison of adherence assessment methods utilized in the United States: perspectives of researchers, HIV-infected children, and their caregivers.
Martin S, Elliott-DeSorbo DK, Calabrese S, Wolters PL, Roby G, Brennan T, Wood LV.
AIDS Patient Care STDS. 2009 Aug;23(8):593-601.

Neurodevelopment of children under 3 years of age with Smith-Magenis syndrome.
Wolters PL, Gropman AL, Martin SC, Smith MR, Hildenbrand HL, Brewer CC, Smith AC.
Pediatr Neurol. 2009 Oct;41(4):250-8.

Stressful life events and their relationship to psychological and medical functioning in children and adolescents with HIV infection.
Elliott-DeSorbo DK, Martin S, Wolters PL.
J Acquir Immune Defic Syndr. 2009 Nov 1;52(3):364-70.

Neuropsychological testing and biomarkers in the management of brain metastases.
Baschnagel A, Wolters PL, Camphausen K.
Radiat Oncol. 2008 Sep 17;3:26

Detection and characterization of neurotoxicity in cancer patients using proton MR spectroscopy.
Steffen-Smith EA, Wolters PL, Albert PS, Baker EH, Shimoda KC, Barnett AS, Warren KE.
Childs Nerv Syst. 2008 Jul;24(7):807-13. Epub 2008 Feb 22.

Phase I trial of pirfenidone in children with neurofibromatosis type 1 and plexiform neurofibromas.
Babovic-Vuksanovic, D., Widemann, B. C., Dombi, E., Gillespie, A., Wolters,P. L., Toledo-Tamula, M. A., O’Neill, B. P., Fox, E., Steinberg, S., MacDonald, T., Beck, H., & Packer, R. (2007).  Pediatric Neurology, 36 (5), 293 - 300.

Immunologic, virologic, and neuropsychologic responses in HIV-infected children receiving their first HAART regimen.
Hazra, R., Jankelevich, S., Mackall, C., Avila, N., Wolters, P., Civitello, L., Jacobsen, F., Steinberg, S., & Yarchoan, R. (2007). Viral Immunology, 20 (1), 131 - 141.

Very high-dose methotrexate (33.6 g/m2) as CNS preventive therapy for childhood acute lymphoblastic leukemia: Results of National Cancer Institute/Children’s Cancer Group trials CCG-191P, CCG-134P, and CCG-144P.
Nathan, P. C., Whitcomb, T., Wolters, P. L., Steinberg, S. M., Balis, F. M. Brouwers, P., Hunsberger, S., Feusner, J., Sather, H., Miser, J., Odom, L. F., Poplack, D., Reaman, G., Bleyer, W. A. (2006). Leukemia & Lymphoma, 47 (12), 2488 - 2504.

Cognitive functioning in school-aged children with vertically acquired HIV infection being treated with highly active antiretroviral therapy (HAART).
Martin SC, Wolters PL, Toledo-Tamula MA, Zeichner SL, Hazra R, Civitello L.
Dev Neuropsychol. 2006;30(2):633-57.

Coping styles among families of children with HIV infection.
Martin SC, Wolters PL, Klaas PA, Perez L, Wood LV.
AIDS Care. 2004 Apr;16(3):283-92.

Dashed Line

return to the top

This Page Last Reviewed on August 15, 2013

About CCR | Clinical Trials | Research | Employment | Initiatives | News | Events | Site Privacy Policy | Accessibility

A Service of the National Cancer Institute

Department of Health and Human Services National Institutes of Health (NIH) USA Gov